Annabel Wright was prescribed the drug Roaccutane in 2018.
Her mother, Helen Wright, said during an investigation in Northallerton, North Yorkshire, that her daughter had shown no signs of depression and that her death the following year “just didn’t make sense.”
Annabel saw her GP about her acne when she was 12 and was then referred to a dermatologist at Harrogate District Hospital when she was 14.
Ms Wright said she raised the issue of suicide as a potential side effect, during their first hospital appointment, when the doctor suggested Roaccutane.
She told the investigation that the doctor told her that people could commit suicide because they were depressed by their acne.
She said, “And Annabel wasn’t. She wasn’t depressed about her skin.
Ms Wright said she received a leaflet listing the potential side effects – which Deputy Coroner Jonathan Leach said included mood and behavior changes.
Reading the leaflet, Mr Leach said he is warning patients to let their doctors know if their mood changes or if they start having thoughts of harming themselves while taking the drug.
Ms Wright said: “I have not been told that suicidal urges can overcome a perfectly normal person. “
She told the inquest that Annabel’s medicines were also sometimes given to her in a simple box that did not contain any patient information leaflets.
Annabel’s dose of Roaccutane, which was revised every four weeks, was increased in January 2019 and again in March, according to the survey.
But, during an appointment on May 1, 2019, doctors said they would recommend reducing the dosage. Later that night, members of Annabel’s family found her dead, the investigation learned.
When asked by Mr Leach why she thought her daughter’s death and the drug were linked, Ms Wright said: ‘It got over her all of a sudden I’m sure. “
She continued, “There was no indication that she had planned anything.
“His last words to me were ‘don’t wash my pants, I’ll need them tomorrow’. “
The investigation is continuing.
Additional reports by PA